Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)

Randall J. Brenneman, Edward Soffen, Hiram A. Gay, Peter F. Orio, John P. Christodouleas, John C. Baumann, Brian C. Baumann

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/ RTOG 0526)'. Together they form a unique fingerprint.